The European Medicines Agency (EMA) has authorized this Thursday emergency use of vaccines developed by Pfizer / BioNTech Laboratories In children between 5 and 11 years old, It is the first in the European Union to be used for this age group. Twenty-seven thus follows in the wake of the United States, which already authorized the use of this serum for little ones in late October. According to the EMA’s conclusion, the vaccine is safe and effective and will be administered in two doses of 10 mcg, with one-third to be administered to people over the age of 12 with an interval between two out of three weeks.
The first country to authorize the use of Pfizer Serum in children ages 5 to 11 was the United States, after validating its efficacy and safety on October 29. According to the Food and Drug Administration (FDA), the immune response of children in this age group is comparable to that of youth between the ages of 16 and 25 and was 90.7% effective in the prevention of 19.Covid. Regarding the safety of the vaccine, it was tested in 3,100 children and serious side effects were ruled out. However, clinical studies on populations of 4,700 children are ongoing in the United States, Finland, Poland, and Spain. As of October-end, 39% of Covid cases among children below 18 years were in the age group of 5 to 11 years. In addition, 8,300 children in this age group had to be hospitalized and by 17 October, 146 had died.
The new EMA recommendation joins a campaign launched in recent days by the European regulator, the European Centers for Disease Prevention and Control (ECDC) and the European Commission to raise awareness among citizens about the need for vaccination in the case of those . Haven’t done yet, and aim to get a booster dose for those who have already completed the regimen. “The current level of vaccination in the EU will be insufficient to limit the burden of covid19 cases and hospitalization during the winter months and countries with low vaccination rates are at greater risk,” the ECDC director warned on Thursday, Andrea Ammon.
Until now, the general slogan was to offer a booster dose to the elderly or those with weakened immune systems, although the EMA already acknowledged last week that “sooner or later” normalize the booster dose to “restore and rdquor”. Will happen; After completing the guideline you get the level of security. With infections once again in much of Europe and an epidemiological situation heading for a forced march, the European Union now recommends that governments begin injecting a third dose to all adults over the age of 40. Do it For now, the European regulator has authorized the use of booster doses from drug companies Pfizer and Moderna for people over the age of 18 and is evaluating those from AstraZeneca and Janssen, although there is no date for the study’s conclusion. Not there.